PROCEPT BioRobotics (PRCT) Cash from Operations Growth (1y) (2021 - 2026)
PROCEPT BioRobotics (PRCT) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.20 Bn | 175.91 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.33 Bn | 66.87 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 47.31 Bn | 43.64 Bn | 1.29 Bn | -84.38% |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 185.96% |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | 16.00% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn | 122.43% |
| 10 | PROCEPT BioRobotics | 993.46 Mn | 747.82 Mn | 53.95 Mn | -124.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -124.54% |
| Dec 31, 2025 | 68.12% |
| Sep 30, 2025 | 64.71% |
| Jun 30, 2025 | 4.40% |
| Mar 31, 2025 | 47.41% |
| Dec 31, 2024 | -30.65% |
| Sep 30, 2024 | 0.75% |
| Jun 30, 2024 | 44.47% |
| Mar 31, 2024 | 10.14% |
| Dec 31, 2023 | 1.51% |
| Sep 30, 2023 | 4.57% |
| Jun 30, 2023 | -65.47% |
| Mar 31, 2023 | -97.07% |
| Dec 31, 2022 | -52.79% |
| Sep 30, 2022 | -55.68% |
| Jun 30, 2022 | -32.67% |
| Mar 31, 2022 | -19.96% |
| Dec 31, 2021 | -22.54% |